Global Schizophrenia Drugs Market Research Report - Industry Analysis, Size, Share, Growth, Trends And Forecast till 2025

  • ID:PD021874
  • December 2018
  • Value Market Research
                          

The report on global schizophrenia drugs market evaluates the growth trends of the industry through historical study and estimates future prospects based on comprehensive research. The report extensively provides the market share, growth, trends and forecasts for the study period. The market size in terms of revenue (USD MN) is calculated for the study period along with the details of the factors affecting the market growth (drivers and restraints).
 
Drivers

  • Rising number aging population
  • Increasing expenditure on healthcare
 
Restraints
  • High cost of R&D
 
Furthermore, the report quantifies the market share held by the major players of the industry and provides an in-depth view of the competitive landscape. This market is classified into different segments with detailed analysis of each with respect to geography.
 
The comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved. The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.
 
The report classifies the market into different segments based on therapeutic class and treatment. These segments are studied in detail incorporating the market estimates and forecasts at regional and country level. The segment analysis is useful in understanding the growth areas and probable opportunities of the market.
 
The report also covers the complete competitive landscape of the worldwide market with company profiles of key players such as Alkermes, Allergan, AstraZeneca, Bristol-Myers Squibb and Company, Eli Lilly, Johnson & Johnson, Pfizer, Sumitomo Dainippon Pharma, and Vanda Pharmaceuticals. A detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.
 
SEGMENTATIONS IN THE REPORT:
By Therapeutic Class:
  • Second-Generation Antipsychotics
    • Risperdal (Risperidone)
    • Invega (Paliperidone)
    • Zyprexa (Olanzapine)
    • Geodon (Ziprasidone)
    • Seroquel (Quetiapine)
    • Latuda (Lurasidone)
    • Aristada (Aripiprazole Lauroxil)
    • Fanapt (Iloperidone)
    • Saphris (Asenapine)
    • Vraylar (Cariprazine)
  • Third-Generation Antipsychotics
    • Abilify (Aripiprazole)
  • Others
    • First-Generation Antipsychotics
    • Generics
 
By Treatment:
  • Oral Antipsychotics
  • Injectable Antipsychotics
 
By Geography:
  • North America (NA) – US, Canada & Rest of North America
  • Europe (EU) – UK, Germany, France & Rest of Europe
  • Asia Pacific (APAC) – China, Japan, India & Rest of APAC
  • Latin America (LA) – Brazil & Rest of Latin America
  • Middle East & Africa (MEA) – Middle East and Africa
 
METHODOLOGY:
A combination of primary and secondary research has been used to determine the market estimates and forecasts. Sources used for secondary research include (but not limited to) Paid Data Sources, Company Websites, Technical Journals, Annual Reports, SEC Filings and various other industry publications. Specific details on methodology used for this report can be provided on demand. 

  • DecisionDatabases.com also provides specific research reports as per Client requirement.
  • Based on the feasibility, data can be provided for custom segmentation
 
DELIVERABLE OPTIONS:
 
DecisionDatabases.com also provides Mini Report and Sections of Reports, in case Client does not want to buy the full report: 
  • Market Data Sheet with all Tables and Graphs
  • Mini Report
  • Analysis
    • Drivers
    • Restraints
    • SWOT Analysis
    • Patent Analysis
  • Application Analysis
  • Product Analysis
  • Geography Analysis
  • Company Analysis
  • Competitive Landscape
  • Location of Plants
  • Company Profiles

1. INTRODUCTION

  • Report Description
  • Research Scope
  • Research Methodology
 
2. EXECUTIVE SUMMARY
  • Market Highlight
  • Global Schizophrenia Drugs Market: Snapshot
 
3. MARKET ANALYSIS
  • Introduction
  • Value Chain Analysis
  • Drivers
  • Restraints
  • Opportunities
  • Porter’s Five Forces Analysis
 
4. SCHIZOPHRENIA DRUGS MARKET ANALYSIS BY THERAPEUTIC CLASS
  • Market In Second-Generation Antipsychotics
    • Market In Risperdal (Risperidone)
    • Market In Invega (Paliperidone)
    • Market In Zyprexa (Olanzapine)
    • Market In Geodon (Ziprasidone)
    • Market In Seroquel (Quetiapine)
    • Market In Latuda (Lurasidone)
    • Market In Aristada (Aripiprazole Lauroxil)
    • Market In Fanapt (Iloperidone)
    • Market In Saphris (Asenapine)
    • Market In Vraylar (Cariprazine)
  • Market In Third-Generation Antipsychotics
    • Market In Abilify (Aripiprazole)
  • Market In Others
    • Market In First-Generation Antipsychotics
    • Market In Generics
 
5. SCHIZOPHRENIA DRUGS MARKET ANALYSIS BY TREATMENT
  • Market In Oral Antipsychotics
  • Market In Injectable Antipsychotics
 
6. SCHIZOPHRENIA DRUGS MARKET ANALYSIS BY GEOGRAPHY
  • North America (NA)
    • North America Market Estimates
    • North America Market Estimates By Country
    • United States (U.S.)
    • Canada
    • Rest Of North America
  • Europe (EU)
    • Europe Market Estimates
    • Europe Market Estimates By Country
    • United Kingdom (UK)
    • Germany
    • France
    • Rest Of Europe
  • Asia Pacific (APAC)
    • Asia Pacific Market Estimates
    • Asia Pacific Market Estimates By Country  
    • China
    • Japan
    • India
    • Rest Of Asia Pacific   
  • Latin America (LA)   
    • Latin America Market Estimates
    • Latin America Market Estimates By Country
    • Brazil
    • Rest Of Latin America
  • Middle East And Africa (MEA)   
    • Middle East And Africa Market Estimates
    • Middle East And Africa Market Estimates By Country
    • Middle East
    • Africa
 
7. COMPETITIVE LANDSCAPE OF THE SCHIZOPHRENIA DRUGS COMPANIES
  • Market Competition
  • Partnerships/Collaborations/Agreements
  • Mergers And Acquisitions
  • New Product Launches
  • Other Developments
 
8. COMPANY PROFILES OF THE SCHIZOPHRENIA DRUGS INDUSTRY (Company Overview, Financial, Major Products & Recent Development)
  • Alkermes
  • Allergan
  • AstraZeneca
  • Bristol-Myers Squibb and Company
  • Eli Lilly
  • Johnson & Johnson
  • Pfizer
  • Sumitomo Dainippon Pharma
  • Vanda Pharmaceuticals
 
* Tentative TOC 

Related Categories
Pharmaceuticals
Related Reports
Global Tigecycline Market Insights, Forecast to 2025

Tigecycline Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


Global Caffeine Market Insights, Forecast to 2025

Caffeine Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the forecast  read more..


Global Rabies Vaccine Market Insights, Forecast to 2025

Rabies Vaccine Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under the  read more..


United States Parkinsons Disease Drug Market Report 2018-2025

The United States Parkinsons Disease Drug market research report is the study prepared by analysts, which contain a detailed analysis of drivers,  read more..


Global Radiopharmaceuticals Market Insights, Forecast to 2025

Radiopharmaceuticals Market Research Report offered by DecisionDatabases.com provides a detailed study on the industrial development of the market under  read more..


Global Neurorehabilitation System Market Research Report

Neurorehabilitation system is as innovative technological solution to monitor and review the activity of nervous systems. It is a relatively new method  read more..


Global Molecular Biology Kits And Reagents Market Research Report

The global molecular biology kits and reagents market is expected to grow at a CAGR of ~7% from 2013 to 2018. A number of factors such as rise in  read more..


Global High Acuity Care Information Systems Market Research Report

The global high acuity care information systems market is expected to grow at a CAGR of ~4% from 2013 to 2018. A number of factors such as growing focus  read more..


Global Regenerative Medicine Market Research Report

The global regenerative medicine market was estimated to be at ~$4.5 billion in 2013.   A number of factors such as increasing bone related  read more..


Global Skin Cancer Diagnostics Market Research Report

Cancers of skin tissues are one of the major types of cancers in the world. In recent years, more than 40% of all cancers in the U.S. have been skin  read more..